Cardiac output measurement with metabolizable analyte containing fluid

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5928155
SERIAL NO

09040167

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Cardiac output is measured utilizing a catheter in conjunction with the indicator dilution technique. Non-thermal analyte-containing fluid is used as the injectate. This fluid is biocompatible with and metabolizable within the body of the patient. An analyte concentration sensor is mounted upon the catheter and located downstream within the bloodstream from the port from which the analyte-containing fluid is expressed. Because of the matching of rapid concentration sensor response with an analyte-containing fluid which is metabolizable, the measurement of cardiac output may be carried out as often as about one to three minutes in conjunction with an infusion interval substantially less than the measurement frequency interval. The analyte-containing fluids are selected from a group consisting of ammoniacal fluid, heparin, ethanol, a carbon dioxide releasing fluid, glucose, and anesthesia agent. The system performs in conjunction with a microprocessor-driven controller which automates the measurement procedure and provides a display of cardiac output and various cardiovascular parameters.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CARDIOX CORPORATION4140 TULLER ROAD SUITE 104 COLUMBUS US OH 43017

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Eggers, Philip E Dublin, OH 237 71242
Huntley, Scott P Danville, CA 20 967
Khalil, Gamal Eddin Redmond, WA 1 244

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation